Status:
COMPLETED
Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia
Lead Sponsor:
Vinmec Research Institute of Stem Cell and Gene Technology
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
1-6 years
Phase:
PHASE1
Brief Summary
To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia
Detailed Description
The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International Hospital, Ha...
Eligibility Criteria
Inclusion
- The patient is diagnosis Bronchopulmonary Dysplasia (premature and depends on oxygen until 28 days old
- Gender: either sex
- Year old \< 6 months
- Weight ≥ 2 kg
- Agree to participate in the study.
Exclusion
- Severe congenital malformation.
- Other severe conditions (active pulmonary bleeding, evidence of active infections).
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04062136
Start Date
March 1 2019
End Date
November 30 2020
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, Vietnam, 100000